Menu
Back to Journals » OncoTargets and Therapy » Volume 15
Review
Profile of Margetuximab: Evidence to Date in the Targeted Treatment of Metastatic HER2-positive Breast Cancer
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 7,585 | Dovepress* | 5,845+ | 299 | 6,144 | |
| PubMed Central* | 1,740 | 224 | 1,964 | ||
| Totals | 7,585 | 523 | 8,108 | ||
| *Since 28 April 2022 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 1 |
View citations on PubMed Central and Google Scholar